NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.

NEJM Interviews
29/03/2023 6 min

Listen "NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic."

Descargar episodio Ver en sitio original

Episode Synopsis


Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.

More episodes of the podcast NEJM Interviews

NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. 07/01/2026
NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. 31/12/2025
NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. 17/12/2025
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. 10/12/2025
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 03/12/2025
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 26/11/2025
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 19/11/2025
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12/11/2025
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 05/11/2025
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 22/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA